China Literature (FRA:C2X) YoY EBITDA Growth: -63.12% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:C2X China Literature Ltd FRA:C2X
77 GF Score
Price €2.10
GF Value €3.07
! 5 Warning Signs
View Full Analysis

What is China Literature YoY EBITDA Growth?

China Literature FRA:C2X +0.99% 77 YoY EBITDA Growth is -63.12% as of Jun. 2026. GuruFocus rates FRA:C2X with a GF Score™ of 77/100 and a GF Value™ of €3.07. The stock has 5 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. China Literature's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was -63.12%.

China Literature's EBITDA per Share for the six months ended in Jun. 2026 was €0.05.

China Literature YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for China Literature's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Literature YoY EBITDA Growth Chart

China Literature Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 164.72 -59.48 -6.48 -106.15 -812.50

China Literature Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.31 -222.06 64.87 -125.30 -63.12
FRA:C2X
77GF Score
China Literature Ltd FRA:C2X
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Literature YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

China Literature's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(-0.073--0.008)/ | -0.008 |
=-812.50 %

China Literature's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(0.045-0.122)/ | 0.122 |
=-63.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -63.12% mean?
China Literature (FRA:C2X) has a YoY EBITDA Growth of -63.12% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for China Literature and its competitors.
Is China Literature's YoY EBITDA Growth too high?
China Literature's current YoY EBITDA Growth is -63.12%. Overall, China Literature has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does China Literature's YoY EBITDA Growth compare to GOOGL and META?
China Literature's YoY EBITDA Growth of -63.12% can be compared against companies in the Interactive Media industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for an Interactive Media company?
A good YoY EBITDA Growth depends on the Interactive Media industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for China Literature and its competitors. China Literature's current YoY EBITDA Growth is -63.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Literature stock overvalued right now?
China Literature (FRA:C2X) has a current YoY EBITDA Growth of -63.12%. The stock's GF Value™ is €3.07, compared to a current price of €2.10 — trading 31.6% below its estimated fair value. The current YoY EBITDA Growth is -63.12%. China Literature's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For China Literature (FRA:C2X), the current YoY EBITDA Growth is -63.12% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Literature (FRA:C2X) Overvalued in 2026?

Based on GuruFocus' analysis, China Literature stock appears to be undervalued. The current stock price of €2.10 is trading 31.6% below its estimated GF Value™ of €3.07.

Key valuation signals for FRA:C2X:

  • YoY EBITDA Growth: -63.12%
  • GF Value™: €3.07 vs. price of €2.10 (31.6% below fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the FRA:C2X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Literature Business Description

Other Exchanges CHLLF:USA00772:Hong Kong
Address No. 5169 Binjiang Avenue, N3 Lujiazui Binjiang Center, Pudong New Area, Shanghai, CHN, 200135
China Literature Ltd is a Chinese online literature and intellectual property company spun off from Tencent. It operates platforms such as QQ Reading and Qidian, where readers access serialized novels and other text works, paying per chapter or through subscriptions, with additional revenue from advertising and game publishing. The company also cultivates and brokers writers, and commercializes copyrights by licensing its library of literary works for adaptation into films, television series, animation, and games. Its segments comprise online business, which generates most revenue, and intellectual property operations and others, covering copyright licensing, adaptation rights, physical book sales, and in-house game operations. Its primary market is China, serving a large base of online readers and writers, with Tencent's ecosystem providing distribution and content synergies.
77GF Score

Get the complete analysis for FRA:C2X

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.10
Price
€3.07
GF Value